FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1972938596> ?p ?o ?g. }

• W1972938596 endingPage "665" @default.
• W1972938596 startingPage "654" @default.
• W1972938596 abstract "Recent studies suggesting an increased cancer risk with glucose-lowering agents have received widespread publicity. The objectives of this study were to evaluate the comparability in underlying cancer risk and patterns of cancer risk over time with different glucose-lowering agents. The General Practice Research Database (GPRD) was used to identify cohorts of new users. Cancer outcomes were obtained from the GPRD, Hospital Episode Statistics and cancer registries. Relative rates of cancer comparing different glucose-lowering agents were estimated using Poisson regression. A total of 206,940 patients was identified. There was no difference in cancer risk and quartile for HbA1c value. There were differences in cancer incidence in the first 6 months after starting treatment (adjusted relative rate of 0.83 [95% CI 0.70, 0.99] with thiazolidinediones, 1.34 [95% CI 1.19, 1.51] with sulfonylureas and 1.79 [95% CI 1.53, 2.10] with insulin, compared with metformin). Insulin users had decreasing cancer incidence over time (adjusted relative rate of 0.58 [95% CI 0.50, 0.68] during months 6–24, relative rate of 0.50 [95% CI 0.42, 0.59] during months 25–60 and relative rate of 0.48 [95% CI 0.40, 0.59] during months 60+) compared with months 0–6 after starting insulin. Similar patterns were found with sulfonylureas and metformin. There were no increases over time with insulin glargine (A21Gly, B31Arg, B32Arg human insulin; relative rate of 0.70 [95% CI 0.52, 0.95], 0.77 [95% CI 0.56, 1.07] and 0.60 [95% CI 0.36, 1.02], respectively, for 6–24, 25–60 and >60 months). These findings do not provide evidence of either beneficial or adverse effects of glucose-lowering agents on cancer risk and are consistent with changes in diabetes treatment in the few months prior to the diagnosis of cancer." @default.
• W1972938596 created "2016-06-24" @default.
• W1972938596 creator A5016347038 @default.
• W1972938596 creator A5054001832 @default.
• W1972938596 creator A5058857513 @default.
• W1972938596 creator A5074680661 @default.
• W1972938596 date "2011-11-30" @default.
• W1972938596 modified "2023-10-17" @default.
• W1972938596 title "Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data" @default.
• W1972938596 cites W1593442063 @default.
• W1972938596 cites W1965111919 @default.
• W1972938596 cites W1971343583 @default.
• W1972938596 cites W1971540233 @default.
• W1972938596 cites W1985300799 @default.
• W1972938596 cites W1999265936 @default.
• W1972938596 cites W2018221159 @default.
• W1972938596 cites W2026967508 @default.
• W1972938596 cites W2044376073 @default.
• W1972938596 cites W2048412570 @default.
• W1972938596 cites W2071216735 @default.
• W1972938596 cites W2073868367 @default.
• W1972938596 cites W2085331940 @default.
• W1972938596 cites W2092389956 @default.
• W1972938596 cites W2103440718 @default.
• W1972938596 cites W2108632093 @default.
• W1972938596 cites W2108747912 @default.
• W1972938596 cites W2109000468 @default.
• W1972938596 cites W2110271384 @default.
• W1972938596 cites W2117636763 @default.
• W1972938596 cites W2117938858 @default.
• W1972938596 cites W2121225884 @default.
• W1972938596 cites W2127753192 @default.
• W1972938596 cites W2127908441 @default.
• W1972938596 cites W2149431936 @default.
• W1972938596 cites W2155997251 @default.
• W1972938596 cites W2156370651 @default.
• W1972938596 cites W2163589808 @default.
• W1972938596 cites W2163691729 @default.
• W1972938596 cites W2164595809 @default.
• W1972938596 cites W2169214947 @default.
• W1972938596 doi "https://doi.org/10.1007/s00125-011-2390-3" @default.
• W1972938596 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22127412" @default.
• W1972938596 hasPublicationYear "2011" @default.
• W1972938596 type Work @default.
• W1972938596 sameAs 1972938596 @default.
• W1972938596 citedByCount "109" @default.
• W1972938596 countsByYear W19729385962012 @default.
• W1972938596 countsByYear W19729385962013 @default.
• W1972938596 countsByYear W19729385962014 @default.
• W1972938596 countsByYear W19729385962015 @default.
• W1972938596 countsByYear W19729385962016 @default.
• W1972938596 countsByYear W19729385962017 @default.
• W1972938596 countsByYear W19729385962018 @default.
• W1972938596 countsByYear W19729385962019 @default.
• W1972938596 countsByYear W19729385962020 @default.
• W1972938596 countsByYear W19729385962021 @default.
• W1972938596 countsByYear W19729385962022 @default.
• W1972938596 countsByYear W19729385962023 @default.
• W1972938596 crossrefType "journal-article" @default.
• W1972938596 hasAuthorship W1972938596A5016347038 @default.
• W1972938596 hasAuthorship W1972938596A5054001832 @default.
• W1972938596 hasAuthorship W1972938596A5058857513 @default.
• W1972938596 hasAuthorship W1972938596A5074680661 @default.
• W1972938596 hasBestOaLocation W19729385961 @default.
• W1972938596 hasConcept C120665830 @default.
• W1972938596 hasConcept C121332964 @default.
• W1972938596 hasConcept C121608353 @default.
• W1972938596 hasConcept C126322002 @default.
• W1972938596 hasConcept C167704817 @default.
• W1972938596 hasConcept C2779306644 @default.
• W1972938596 hasConcept C2779920387 @default.
• W1972938596 hasConcept C2780323712 @default.
• W1972938596 hasConcept C2780668416 @default.
• W1972938596 hasConcept C2908647359 @default.
• W1972938596 hasConcept C44249647 @default.
• W1972938596 hasConcept C61511704 @default.
• W1972938596 hasConcept C68443243 @default.
• W1972938596 hasConcept C71924100 @default.
• W1972938596 hasConcept C73269764 @default.
• W1972938596 hasConcept C82789193 @default.
• W1972938596 hasConcept C99454951 @default.
• W1972938596 hasConceptScore W1972938596C120665830 @default.
• W1972938596 hasConceptScore W1972938596C121332964 @default.
• W1972938596 hasConceptScore W1972938596C121608353 @default.
• W1972938596 hasConceptScore W1972938596C126322002 @default.
• W1972938596 hasConceptScore W1972938596C167704817 @default.
• W1972938596 hasConceptScore W1972938596C2779306644 @default.
• W1972938596 hasConceptScore W1972938596C2779920387 @default.
• W1972938596 hasConceptScore W1972938596C2780323712 @default.
• W1972938596 hasConceptScore W1972938596C2780668416 @default.
• W1972938596 hasConceptScore W1972938596C2908647359 @default.
• W1972938596 hasConceptScore W1972938596C44249647 @default.
• W1972938596 hasConceptScore W1972938596C61511704 @default.
• W1972938596 hasConceptScore W1972938596C68443243 @default.
• W1972938596 hasConceptScore W1972938596C71924100 @default.
• W1972938596 hasConceptScore W1972938596C73269764 @default.
• W1972938596 hasConceptScore W1972938596C82789193 @default.
• W1972938596 hasConceptScore W1972938596C99454951 @default.

• next